Henry Schein, Inc. HSIC
86.37
0.84
0.98%
as of 25 Sep
- Market cap
- $9.5B
- P/E
- 25.0×
Follow HSIC
Indexes
indicate stock being part of an index,
Insider Buys
alert about insiders buying in the last 12 month
Henry Schein, Inc. (HSIC) Current ratio
Henry Schein, Inc.'s current ratio at the end of the quarter to 30 June 2026 was 1.3×, down 0.1× from fiscal 2025 (1.4×). Over the past ten years it has ranged from 1.3× (fiscal 2018) to 1.8× (fiscal 2022); the current reading is higher than 18% of that period. That is above the Medical Distribution industry median of 1.1× and below the Healthcare sector median of 3.0×.
Current ratio, annual
Annual
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 1.4× | (2.68%) |
| FY2024 | 1.4× | (15.05%) |
| FY2023 | 1.7× | (6.71%) |
| FY2022 | 1.8× | 7.62% |
| FY2021 | 1.7× | 0.34% |
| FY2020 | 1.7× | 4.91% |
| FY2019 | 1.6× | 22.03% |
| FY2018 | 1.3× | (10.19%) |
| FY2017 | 1.4× | 0.26% |
| FY2016 | 1.4× | (4.28%) |
Quarterly
| Period | Current ratio | Change |
|---|---|---|
| Jun 2026 | 1.3× | (3.29%) |
| Mar 2026 | 1.4× | (1.39%) |
| Dec 2025 | 1.4× | (0.92%) |
| Sep 2025 | 1.4× | (1.08%) |
| 42 more quarters | Free account |
Against its own ten years
Low 1.3×
High 1.8×
Ten-year median
1.5×
Current reading's percentile
18
Current ratio against peers
| Company | Current ratio |
|---|---|
| FOCL FocalTherics compare | 1.6× |
| AHG Akso Health Group Sponsored ADR compare | 1.5× |
| HSIC Henry Schein, Inc. | 1.3× |
| YI 111, Inc. Sponsored ADR compare | 1.1× |
| COSM Cosmos Health Inc. compare | 1.1× |
| COR Cencora, Inc. compare | 0.9× |
| MCK McKesson Corporation compare | 0.9× |
| CAH Cardinal Health, Inc. compare | 0.9× |
| ACH Accendra Health, Inc. compare | 0.4× |
| Medical Distribution industry median | 1.1× |
| Healthcare sector median | 3.0× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on HSIC
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement